Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Maglione

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nutrients|March 28, 2024
Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern ItalyMatteo Bronzini, Alessandro Maglione, Rachele Rosso, et al.
Frontiers in Immunology|July 6, 2023
Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosisAlessandro Maglione, Rachele Francese, Irene Arduino, et al.
Brain Sciences|January 28, 2026
Targeting Lifestyle in CNS Inflammatory Demyelinating Diseases: Insights from Diet and Exercise as Potential Disease ModifiersEleonora Virgilio, Federico Abate Daga, Matteo Bronzini, et al.
Cancers|January 22, 2021
The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding PartnerMuhammad Shahzad Ali, Cristina Panuzzo, Chiara Calabrese, et al.
BMC Bioinformatics|December 14, 2020
Computational modeling of the immune response in multiple sclerosis using epimod frameworkSimone Pernice, Laura Follia, Alessandro Maglione, et al.
BMC Bioinformatics|December 12, 2019
A computational approach based on the colored Petri net formalism for studying multiple sclerosisSimone Pernice, Marzio Pennisi, Greta Romano, et al.
International Journal of Molecular Sciences|January 21, 2023
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem CellsCristina Panuzzo, Lucrezia Pironi, Alessandro Maglione, et al.
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Frontiers in Immunology|March 17, 2022
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-UpSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
International Journal of Molecular Sciences|October 21, 2020
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic CellsChiara Calabrese, Cristina Panuzzo, Serena Stanga, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nutrients|March 28, 2024
Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern ItalyMatteo Bronzini, Alessandro Maglione, Rachele Rosso, et al.
Frontiers in Immunology|July 6, 2023
Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosisAlessandro Maglione, Rachele Francese, Irene Arduino, et al.
Brain Sciences|January 28, 2026
Targeting Lifestyle in CNS Inflammatory Demyelinating Diseases: Insights from Diet and Exercise as Potential Disease ModifiersEleonora Virgilio, Federico Abate Daga, Matteo Bronzini, et al.
Cancers|January 22, 2021
The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding PartnerMuhammad Shahzad Ali, Cristina Panuzzo, Chiara Calabrese, et al.
BMC Bioinformatics|December 14, 2020
Computational modeling of the immune response in multiple sclerosis using epimod frameworkSimone Pernice, Laura Follia, Alessandro Maglione, et al.
BMC Bioinformatics|December 12, 2019
A computational approach based on the colored Petri net formalism for studying multiple sclerosisSimone Pernice, Marzio Pennisi, Greta Romano, et al.
International Journal of Molecular Sciences|January 21, 2023
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem CellsCristina Panuzzo, Lucrezia Pironi, Alessandro Maglione, et al.
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Frontiers in Immunology|March 17, 2022
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-UpSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
International Journal of Molecular Sciences|October 21, 2020
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic CellsChiara Calabrese, Cristina Panuzzo, Serena Stanga, et al.
Pageof 3